Wells Fargo Releases a Hold Rating on McKesson (MCK)

In a report released today, Stephen Baxter from Wells Fargo assigned a Hold rating to McKesson, with a price target of $925.00.

Claim 30% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Baxter is an analyst with an average return of -1.4% and a 42.59% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Elevance Health, Cencora, and Community Health.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for McKesson with a $981.22 average price target.

Based on McKesson’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $106.16 billion and a net profit of $1.19 billion. In comparison, last year the company earned a revenue of $95.29 billion and had a net profit of $879 million

Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MCK in relation to earlier this year. Most recently, in February 2026, Maria Martinez, a Director at MCK sold 349.00 shares for a total of $328,011.14.